These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28646489)

  • 41. Epigenetic regulation of plastin 3 expression by the macrosatellite DXZ4 and the transcriptional regulator CHD4.
    Strathmann EA; Hölker I; Tschernoster N; Hosseinibarkooie S; Come J; Martinat C; Altmüller J; Wirth B
    Am J Hum Genet; 2023 Mar; 110(3):442-459. PubMed ID: 36812914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted deletion of the zebrafish actin-bundling protein L-plastin (lcp1).
    Kell MJ; Riccio RE; Baumgartner EA; Compton ZJ; Pecorin PJ; Mitchell TA; Topczewski J; LeClair EE
    PLoS One; 2018; 13(1):e0190353. PubMed ID: 29293625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoclast-specific Plastin 3 knockout in mice fail to develop osteoporosis despite dramatic increased osteoclast resorption activity.
    Maus I; Dreiner M; Zetzsche S; Metzen F; Ross BC; Mählich D; Koch M; Niehoff A; Wirth B
    JBMR Plus; 2024 Jan; 8(1):ziad009. PubMed ID: 38549711
    [No Abstract]   [Full Text] [Related]  

  • 44. A common gene variant in PLS3 predicts colon cancer recurrence in women.
    Szkandera J; Winder T; Stotz M; Weissmueller M; Langsenlehner T; Pichler M; Samonigg H; Renner W; Gerger A; Absenger G
    Tumour Biol; 2013 Aug; 34(4):2183-8. PubMed ID: 23549633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects.
    Petit F; Longoni M; Wells J; Maser RS; Bogenschutz EL; Dysart MJ; Contreras HTM; Frénois F; Pober BR; Clark RD; Giampietro PF; Ropers HH; Hu H; Loscertales M; Wagner R; Ai X; Brand H; Jourdain AS; Delrue MA; Gilbert-Dussardier B; Devisme L; Keren B; McCulley DJ; Qiao L; Hernan R; Wynn J; Scott TM; Calame DG; Coban-Akdemir Z; Hernandez P; Hernandez-Garcia A; Yonath H; Lupski JR; Shen Y; Chung WK; Scott DA; Bult CJ; Donahoe PK; High FA
    Am J Hum Genet; 2023 Oct; 110(10):1787-1803. PubMed ID: 37751738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent Discoveries in Monogenic Disorders of Childhood Bone Fragility.
    Mäkitie RE; Kämpe AJ; Taylan F; Mäkitie O
    Curr Osteoporos Rep; 2017 Aug; 15(4):303-310. PubMed ID: 28646443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.
    Loid P; Hauta-Alus H; Mäkitie O; Magnusson P; Mäkitie RE
    Front Endocrinol (Lausanne); 2022; 13():954730. PubMed ID: 36157448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The intricate mechanism of PLS3 in bone homeostasis and disease.
    Zhong W; Pathak JL; Liang Y; Zhytnik L; Pals G; Eekhoff EMW; Bravenboer N; Micha D
    Front Endocrinol (Lausanne); 2023; 14():1168306. PubMed ID: 37484945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia.
    Mahat U; Garg B; Yang CY; Mehta H; Hanna R; Rogers HJ; Flagg A; Ivanov AI; Corey SJ
    Blood Adv; 2022 Apr; 6(8):2581-2594. PubMed ID: 34991157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L-plastin associated syndrome of immune deficiency and hematologic cytopenia.
    Hernandez RA; Hearn JI; Bhoopalan V; Hamzeh AR; Kwong K; Diamand K; Davies A; Li FJ; Padmanabhan H; Milne R; Ballard F; Spensberger D; Gardiner EE; Miraghazadeh B; Enders A; Cook MC
    J Allergy Clin Immunol; 2024 Sep; 154(3):767-777. PubMed ID: 38710235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The actin-bundling protein, PLS3, is part of the mechanoresponsive machinery that regulates osteoblast mineralization.
    Chin SM; Unnold-Cofre C; Naismith T; Jansen S
    Front Cell Dev Biol; 2023; 11():1141738. PubMed ID: 38089885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene.
    Mancini M; Chapurlat R; Isidor B; Desjonqueres M; Couture G; Guggenbuhl P; Coutant R; El Chehadeh S; Fradin M; Frazier A; Goldenberg A; Guillot P; Koumakis E; Mehsen-Cêtre N; Rossi M; Schaefer É; Sigaudy S; Porquet-Bordes V; Fontanges É; Letard P; Edouard T; Javier RM; Cohen-Solal M; Funck-Brentano T; Collet C
    Calcif Tissue Int; 2024 Nov; 115(5):591-598. PubMed ID: 39316135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phospholipid scramblase 3 controls mitochondrial structure, function, and apoptotic response.
    Liu J; Dai Q; Chen J; Durrant D; Freeman A; Liu T; Grossman D; Lee RM
    Mol Cancer Res; 2003 Oct; 1(12):892-902. PubMed ID: 14573790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PLS3 Overexpression Delays Ataxia in
    Janzen E; Wolff L; Mendoza-Ferreira N; Hupperich K; Delle Vedove A; Hosseinibarkooie S; Kye MJ; Wirth B
    Front Neurosci; 2019; 13():993. PubMed ID: 31607845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.
    Boonk SE; Zoutman WH; Putter H; Ram-Wolff C; Felcht M; Klemke CD; Ranki A; Quaglino P; Whittaker S; Bagot M; Willemze R; Vermeer MH
    J Invest Dermatol; 2017 Mar; 137(3):754-757. PubMed ID: 27984038
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical, Genetics, and Bioinformatic Characterization of Mutations Affecting an Essential Region of
    Chen T; Wu H; Zhang C; Feng J; Chen L; Xie R; Wang F; Chen X; Zhou H; Sun H; Xiao F
    Int J Endocrinol; 2018; 2018():8953217. PubMed ID: 30405713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
    Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
    Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma.
    Galiègue-Zouitina S; Quief S; Hildebrand MP; Denis C; Detourmignies L; Laï JL; Kerckaert JP
    Genes Chromosomes Cancer; 1999 Oct; 26(2):97-105. PubMed ID: 10469447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plastin 3 in X-Linked Osteoporosis: Imbalance of Ca
    Schwebach CL; Kudryashova E; Kudryashov DS
    Front Cell Dev Biol; 2020; 8():635783. PubMed ID: 33553175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.